P406: ENHANCED SIGNIFICANCE OF FLT3-ITD RESIDUAL DISEASE DETECTION ON TREATMENT OUTCOME IN ACUTE MYELOID LEUKEMIA

• T. Grob,
• M. Sanders,
• C. Vonk,
• F. Kavelaars,
• M. Rijken,
• D. Hanekamp,
• P. Gradowska,
• J. Cloos,
• Y. Fløisand,
• M. V. Marwijk Kooy,
• M. Manz,
• G. Ossenkoppele,
• L. Tick,
• V. Havelange,
• B. Löwenberg,
• M. Jongen-Lavrencic,
• P. Valk

Affiliations

T. Grob

1 Hematology, Erasmus Medical Center, Rotterdam

M. Sanders

1 Hematology, Erasmus Medical Center, Rotterdam

C. Vonk

1 Hematology, Erasmus Medical Center, Rotterdam

F. Kavelaars

1 Hematology, Erasmus Medical Center, Rotterdam

M. Rijken

1 Hematology, Erasmus Medical Center, Rotterdam

D. Hanekamp

1 Hematology, Erasmus Medical Center, Rotterdam

P. Gradowska

1 Hematology, Erasmus Medical Center, Rotterdam

J. Cloos

2 Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands

Y. Fløisand

3 Hematology, Oslo University Hospital, Oslo, Norway

M. V. Marwijk Kooy

4 Hematology, Isala Hospital, Zwolle, Netherlands

M. Manz

5 Hematology, University Hospital Zurich, Zurich, Switzerland

G. Ossenkoppele

2 Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands

L. Tick

6 Hematology, Maxima Medisch Centrum, Eindhoven, Netherlands

V. Havelange

7 Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

B. Löwenberg

1 Hematology, Erasmus Medical Center, Rotterdam

M. Jongen-Lavrencic

1 Hematology, Erasmus Medical Center, Rotterdam

P. Valk

1 Hematology, Erasmus Medical Center, Rotterdam